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Summary
Protein feeding is known to decrease hunger and subsequent food intake in animals and humans. It has also been sug-
gested that glucose appearance into portal vein, as occurring during meal assimilation, may induce comparable effects.
Here, we connect these previous observations by reporting that intestinal gluconeogenesis (i.e., de novo synthesis of
glucose) is induced during the postabsorptive time (following food digestion) in rats specifically fed on protein-enriched
diet. This results in glucose release into portal blood, counterbalancing the lowering of glycemia resulting from intestinal
glucose utilization. Comparable infusions into the portal vein of control postabsorptive rats (fed on starch-enriched diet)
decrease food consumption and activate the hypothalamic nuclei regulating food intake. Similar hypothalamic activation
occurs on protein feeding. All these effects are absent after denervation of the portal vein. Thus, portal sensing of intestinal
gluconeogenesis may be a novel mechanism connecting the macronutrient composition of diet to food intake.Introduction
The disorders of food intake have a major impact on the
worldwide expansion of obesity and type 2 diabetes mellitus
(Flier, 2004; Friedman, 2000). This urges the scientific com-
munity to seek novel mechanisms of control of the sensations
of hunger and satiety. The brain, particularly specific hypothal-
amic nuclei, plays a crucial role in this control. It ceaselessly
senses nutrients and hormones provided by the periphery, and
adapts energy intake and expenditure to the needs of the body
(Obici et al., 2003; Schwartz and Morton, 2002).
In this context, it is well known that protein feeding de-
creases hunger sensation and subsequent food intake in ani-
mals and human (Barkeling et al., 1990; Booth et al., 1970;
Jean et al., 2001; Rolls et al., 1988). However, the mechanism
by which proteins induce their specific hypophagia effects is
still unsolved (Barkeling et al., 1990; Booth et al., 1970; Jean
et al., 2001; Rolls et al., 1988). Actually, the major hormones
decreasing food intake produced by the body are either unaf-
fected (leptin) or even slightly decreased (insulin) if the propor-
tion of protein in the diet is increased (Jean et al., 2002). Simi-
larly, the participation of the two main gut-derived hormones
possibly involved in food intake i.e., cholescystokinin (Moran,
2000) and PYY3-36 (Batterham et al., 2002; Halatchev and
Cone, 2005) seems excluded. In fact, PYY3-36 is unspecifically
secreted in response to food in proportion to the calories in-
gested (Pedersen-Bjergaard et al., 1996; Schwartz and Morton,
2002) and the cholecystokinin release is stimulated by proteins
as well as by lipids in animals (Backus et al., 1995; Douglas et
al., 1990) and humans (Hopman et al., 1985), whereas lipidsCELL METABOLISM : NOVEMBER 2005 · VOL. 2 · COPYRIGHT © 2005 Ehave a much lower suppressing effect on food intake than pro-
teins (Rolls et al., 1988).
Besides hormones, glucose per se is a key signaling mole-
cule able to suppress food intake (Thorens and Larsen, 2004).
Contrasting with most of the circulating hormonal signals (for
instance, leptin or insulin), which are supposed to be directly
sensed by the brain (hypothalamus) through the median emi-
nence (Flier, 2004; Schwartz and Morton, 2002), the sensing of
glucose-induced effects takes place in the portal vein (Lang-
hans et al., 2001; Thorens and Larsen, 2004; Tordoff and Fried-
man, 1986; Tordoff et al., 1989). It is dependent on glucose-
sensitive cells present in the wall of the portal vein, the signal
being transmitted to the brain via afferences of the vagus nerve
(Adachi et al., 1984; Schmitt, 1973; Shimizu et al., 1983; Thor-
ens and Larsen, 2004). As a related point, we previously re-
ported that gluconeogenesis genes are expressed in the small
intestine (SI) in rats and humans (Rajas et al., 1999, 2000). This
confers on this tissue the capacity to form glucose and release
it into the portal blood, this capacity actually taking place only
when these genes are induced, such as in fasting and diabetes
(Croset et al., 2001; Mithieux et al., 2004a). Because portal glu-
cose is able to induce hypophagia, this raised the attractive
hypothesis that intestinal gluconeogenesis might have the ca-
pacity to decrease hunger sensation and food intake. More-
over, it as been previously reported that rats fed on a high-
protein and carbohydrate-free diet can adapt very rapidly by
inducing hepatic gluconeogenesis, the induction of the main
liver gluconeogenesis enzymes is even more rapid than during
the adaptation to fasting (Boisjoyeux et al., 1986). Thence, we
tested the hypothesis that protein feeding might induce gluco-LSEVIER INC. DOI 10.1016/j.cmet.2005.09.010 321
A R T I C L Eneogenesis in the SI, which gives the possibility of detecting
glucose release by the portal glucose sensor, and thus of
decreasing food intake.
Results and discussion
Protein feeding induces hypophagia, SI gluconeogenesis,
and portal glucose release during
the postabsorptive period
In agreement with previous results (Jean et al., 2001), rats fed
on a diet moderately enriched in protein (50% by weight as
protein) ate and grew less than rats fed on a control starch
enriched diet (SED) (17% as protein). Rats ate slightly less the
first day they were given the PED, but this was rapidly compen-
sated within a couple days, as previously reported (Jean et al.,
2001). Food intake, monitored over 6 successive days from the
third day on PED feeding, was 17.4 ± 0.6 g/day/rat in PED-fed
rats versus 20.5 ± 0.7g/day/rat in SED-fed rats (mean ± SEM,
n = 6 per group, p < 0.05, Student’s t test for unpaired value).
This represented a 15% lower food intake in PED-fed rats, very
comparable to that previously reported (Jean et al., 2001). This
resulted in a weight gain of 49.8 ± 2.6 g in rats fed on the
protein-enriched diet (PED) versus 60.6 ± 3.1 g in SED-fed rats
(mean ± SEM, n = 8 per group) after 7 days, and 84.7 ± 3.4 g
versus 102.4 ± 2.9 g, respectively, after 15 days (differences
were significant at p < 0.01, Student’s t test for unpaired value),
whereas rats were perfectly matched for weight at the begin-
ning of the experiment: 201.0 ± 1.4 g for SED-fed and 200.7 ±
1.6 g for PED-fed rats. Because rats fed on PED weighed pro-
gressively less, we also expressed the results as kcal ingested
per kg per day during the monitoring period of 6 days. PED-fed
rats ingested 278.0 ± 2.2 kcal/kg/day whereas SED-fed rats
ingested 319.2 ± 2.6 kcal/kg/day. The difference was slightly
lower compared to the expression of results as g of food in-
gested/day/rat, but still significant (p < 0.05, Student’s t test
for unpaired values). It is interesting to mention that the com-
position of the protein diet given herein was chosen on the
basis that rats allowed to self-select the macronutrient compo-
sition of their diet choose a very comparable protein-enriched
diet (Jean et al., 2002). It seems therefore unlikely that the pro-
tein-induced hypophagia might be due to lesser palatability of
the diet or malaise. Also in disagreement with the latter hypoth-
esis, it has been previously reported that protein-feeding de-
creases food intake by inducing satiety phenomena and not
malaise or taste aversion (L’Heureux-Bouron et al., 2004; West-
erterp-Plantenga, 2003). However, because the role of palat-
ability was not addressed here, it could not be formally ex-
cluded that differences in palatabilities of SED and PED may
account at least in part for the effects observed.
In line with our hypothesis, the expression of the two major
regulatory genes of gluconeogenesis in the SI, i.e., glucose-6
phosphatase (Glc6Pase) and phosphoenolpyruvate carboxyki-
nase (PEPCK) (Mithieux et al., 2004b) was dramatically induced
in rats fed on the PED compared to those fed on the SED. A
double induction was observed on the amount of protein de-
tected by immunoblotting (Figures 1A and 1B) and on the en-
zyme activity determined under conditions of maximal velocity
(Figure 1C). Moreover, there was a marked induction by about
80% of the expression of the glutaminase gene in rats fed on
the PED (Figure 1). The latter gene was strongly suggested to
have a crucial potentiating role in SI gluconeogenesis (Mithieux322Figure 1. Induction of gluconeogenesis genes in the rat SI upon PED feeding
A) Representative Western blot analysis of glutaminase and PEPCK in the proxi-
mal jejunum for three rats fed on the SED (left) and 3 rats fed on the PED (right)
for 7 days.
B) Densitometric analysis performed from six rats per group. The results are
expressed as arbitrary units (AU), *, p < 0.05, Student’s t test for unpaired
samples.
C) Enzymatic activities assayed under conditions of maximal velocity (n = 6 per
group) (Mithieux et al., 2004a; Rajas et al., 1999, 2000). The results are expressed
as mol/min/g of wet tissue, *, p < 0.05, Student’s t test for unpaired values.et al., 2004a). The experiments shown in Figure 1 were per-
formed on day 7, but separate experiments clearly indicated
that induction occurred from the first 24 hr of PED feeding
(data not shown). Moreover, results from the proximal jejunum
are shown in Figure 1, but comparable induction occurred in
all parts of the SI, from duodenum up to ileum. It is of note
that in previous studies in which carbohydrates were totally
replaced by protein, induction of gluconeogenesis enzymes
was reported in the liver (Boisjoyeux et al., 1986). In contrast,
no induction of either gluconeogenesis genes occurred in the
liver with the diet moderately enriched in protein used herein
(data not shown). In the liver, this was consistent with the fact
that no change in plasma insulin occurred (Table 1) and, in the
SI, with our previous observation that more than the insulin
status was crucial to determine Glc6Pase gene induction in
this tissue (Mithieux et al., 2004a, 2004b). It must be mentioned
that the induction of gene expression by protein diets in the SI
is not unique to genes of gluconeogenesis. The gene of the
intestinal oligopeptide transporter PepT1 for example was
shown to be markedly induced under such nutritional condi-
tions (Adibi, 2003). In line with the induction of intestine spe-
cific genes by proteins in vivo, protein hydrolysates were
shown to activate in vitro the transcription of cholecystokinin
and proglucagon genes, via cAMP-dependent activation of the
nuclear factor CREB (cAMP response element binding protein)
(Gevrey et al., 2002, 2004). Interestingly, the latter factor was
also shown to be essential in the transcriptional control of
Glc6Pase and PEPCK genes by cAMP (Gautier-Stein et al.,
2005; Quinn et al., 1988).
We then tested whether gluconeogenic gene induction re-CELL METABOLISM : NOVEMBER 2005
Intestinal gluconeogenesis diminishes food intakeTable 1. Plasma glucidic parameters in SED- and PED-fed rats
Fractional Plasma insulin
Feeding pattern [3-3H] glucose specific activity (dpm/mol) Plasma glucose (mmol/l) extraction (pmol/l)
artery vein artery vein
SED 10,539 ± 681 10,738 ± 610 9.3 ± 0.6 8.6 ± 0.5a 0.06 ± 0.01 304 ± 42
PED 1 days 12,298 ± 556 11,874 ± 616a 9.5 ± 0.8 9.2 ± 0.9 0.06 ± 0.02 268 ± 182
PED 2 days 10,394 ± 555 9,777 ± 492b 9.4 ± 0.5 9.6 ± 0.5 0.04 ± 0.01 294 ± 99
PED 3 days 10,802 ± 484 10,273 ± 442b 10.5 ± 0.4 10.6 ± 0.5 0.04 ± 0.01 352 ± 136
PED 7 days 11,143 ± 297 10,401 ± 209a 9.4 ± 0.3 9.5 ± 0.2 0.05 ± 0.01 334 ± 55
PED 15 days 9,659 ± 477 9,011 ± 482a 10.3 ± 0.4 10.1 ± 0.4 0.07 ± 0.02 312 ± 80
PED 2 days + 10,601 ± 800 10,353 ± 609 8.8 ± 0.8 8.3 ± 0.7a 0.07 ± 0.02 329 ± 91
SED 1 day
Rats (n = 8 per group) were either fed on the control SED or fed on SED and then on the PED for 1, 2, 3, 7, and 15 days or the PED for 2 days and the SED for 1 more
day. The results are expressed as mean ± SEM. a,bValue in vein different from that in artery, p < 0.05 and p < 0.01, respectively (Student’s t test for paired values).sulted in the release of glucose into the portal vein, as demon-
strated in fasting or diabetes (Croset et al., 2001; Mithieux et
al., 2004a). Because the SI is also a strong glucose-utilizing
organ, we used the previous combination of arterio-venous
balance determination and glucose tracer dilution analysis to
separate the uptake and release of glucose by the SI (Croset
et al., 2001; Mithieux et al., 2004a). Though rats ate slightly
less the first day they were given the PED (see above), this was
not sufficient to significantly alter plasma glucose and insulin
concentrations in comparison with rats fed on the SED (Table
1). The SI blood flow in rats fed on the PED for one day (6.2 ±
0.7 ml/min) was not different from that in SED-fed rats (5.9 ±
0.9 ml/min), and it was not further modified during the following
days. Rats were deprived of food for 6 hr, anesthetized, and
fitted with catheters. This was a time when the SI was com-
pletely cleared up to the very distal ileum in both SED-fed and
PED-fed rats. This prevented glucose absorbed from the intes-
tinal lumen from giving ambiguous results. It should be noted
that the plasma concentration of cholecystokinin, i.e., the main
candidate hormone putatively affected by protein ingestion
(Jean et al., 2002), was identical in PED-fed rats (for 7 days)
(2.85 ± 0.8 pg/ml, mean ± SEM, n = 6) and in SED-fed rats
(3.82 ± 1.14 pg/ml). Blood was then sampled after 90 min of
[3-3H]-glucose infusion (Croset et al., 2001). The [3-3H]-glucose
specific activity (SA) was the same in portal and arterial blood
in SED-fed rats (Table 1). This was an indication that there was
no release of glucose into the portal blood in these rats. This
also confirmed that food digestion was completed (see above).
There was a significant decrease in plasma glucose concentra-
tion in the portal vein as compared to the artery (Table 1), re-
flecting glucose utilization by the tissue. The intestinal glucose
balance (IGB), calculated from these glucose concentrations,
was in the same order range as that of the intestinal glucose
uptake (IGU), which was deduced from the arterial glucose
concentration and the [3-3H]-glucose removal by the SI (i.e.,
fractional extraction or FX) (Tables 1 and 2). Consequently, the
calculated intestinal glucose release (IGR) was not different
from nought (−3.4 ± 2.7 mol/kg/min, mean ± SEM., n = 8)
(Table 2). These data were in agreement with our previous data
in postabsorptive and/or short-term fasted rats previously fed
a starch-based diet (Croset et al., 2001; Mithieux et al., 2004a).
In contrast, in rats fed on the PED, the glucose SA was signifi-
cantly lower (−3.4%) in the portal compared to arterial blood
from the first day of PED feeding (Table 1). This revealed aCELL METABOLISM : NOVEMBER 2005significant release of unlabeled glucose into the portal blood.
Consequently, the decrease in glycemia observed in the portal
blood was almost negligible as compared to that in SED-fed
rats. From the second day and up to 15 days of PED feeding,
the decrease in glucose SA between the portal vein and the
artery was deeper (around –6%), and there was no more differ-
ence in plasma glycemia between vein and artery (Table 1).
Accordingly, the calculated intestinal glucose balance (IGB)
was lower than that in SED-fed rats from one day of PED feed-
ing onward and then approached zero between 2–15 days (Ta-
ble 2). The intestinal glucose uptake (IGU) was the same in
PED- and SED-fed rats (Table 2) with no alteration throughout
the feeding period. These data revealed a significant intestine
glucose release (IGR) of 6.9 ± 2.1 mol/kg/min, representing
12% of the endogenous glucose production (EGP) the first day
of PED feeding. The glucose release increased twice (13.1 ±
2.8 mol/kg/min or 19% of PEG) from day 2 and underwent
no further change thereafter (Table 2). In PED-fed rats infused
with [U-14C] glutamine, there was a significant (p < 0.05) in-
crease (+3.6%) in the 14C-glucose SA in the portal vein com-
pared to the artery. This indicated that glucose molecules re-
leased by the SI had incorporated 14C-glutamine. This was in
agreement with the increased expression of the glutaminase
gene (Figure 1) and with the fact that glutamine is the main, if
not the only, substrate of SI gluconeogenesis (Croset et al.,
2001; Mithieux, 2001). It was noticeable that the total endoge-
nous glucose production (EGP) was not altered in PED-fed
compared to SED-fed rats, while an intestinal component ap-
peared with PED feeding. This was in agreement with the ob-
servation that glucose production by the liver is proportionally
inhibited by portal glucose appearance (Sindelar et al., 1997).
Interestingly, intestine glucose production was highly charac-
teristic of PED. It was in fact equal to nought in rats fed on the
PED for 2 days and refed on the SED for 1 day (Tables 1 and
2), or in rats fed on a high-fat diet as previously described
(Mithieux et al., 2002) (data not shown). These data strongly
suggested that the induction of gluconeogenic genes in the SI
resulted in the portal release of glucose during the postabsorp-
tive period in rats specifically fed on the PED.
Portal glucose appearance induces hypophagia per se
Next, the question arose of whether such intestinal glucose
fluxes delivered to the portal vein, which were quantitatively
low but continuous, were capable of decreasing food intake in323
A R T I C L ETable 2. Intestinal glucose fluxes in SED- and PED-fed rats
Feeding pattern IGU IGB IGR (% of EGP) EGP
SED 12.9 ± 5.5 16.3 ± 6.0 −3.4 ± 2.7 72.9 ± 4.5
PED 1 days 14.7 ± 5.6 7.9 ± 3.9 6.9 ± 2.1 (12%) 61.9 ± 2.7
PED 2 days 9.0 ± 2.2 −4.1 ± 4.2 13.1 ± 2.8 (19%) 70.7 ± 3.6
PED 3 days 9.7 ± 2.9 −2.8 ± 2.7 12.5 ± 1.9 (17%) 74.5 ± 1.9
PED 7 days 10.4 ± 4.0 −3.9 ± 1.2 14.3 ± 4.1 (21%) 68.9 ± 1.8
PED 15 days 16.5 ± 4.8 4.0 ± 4.4 12.3 ± 2.8 (17%) 73.7 ± 2.4
PED 2 days + SED 1 day 11.7 ± 3.9 8.9 ± 4.3 2.9 ± 3.7 63.6 ± 5.0
Rats were either fed on the control SED or fed on the SED and then on the PED for 1, 2, 3, 7, and 15 days or the PED for 2 days and the SED for 1 more day. All
procedures required for the determination of IGU, IGB, IGR, and EGP are fully described in Experimental Procedures. The results are expressed as mol/kg/min and
are the mean ± SEM (n = 8).a way similar to the previously studied glucose fluxes, which
were quantitatively higher but more transient (the latter being
merely designed to match postprandial glucose absorption)
(Langhans et al., 2001; Tordoff and Friedman, 1986; Tordoff et
al., 1989). Rats were fitted with indwelling catheters into the
portal vein. After one week, allowing complete recovery after
surgery, rats were infused with glucose at 12 and 25 mol/
kg/min, i.e., matching the mean and maximal values of IGR
determined individually in PED-fed, rats respectively. It must
be noted that this rather high scatter in IGR values (Table 2)
may be either intrinsically inherent in IGR or at least partly at-
tributable to the lack of precision of the tracer approach (this
point is discussed in Croset et al., 2001). In separate experi-
ments (data not shown), we checked that there was no modifi-
cation of either plasma glucose or insulin in peripheral blood
induced by such low portal glucose infusions. This was in
keeping with the coordinate suppression of hepatic glucose
production (see above). In a first approach, we studied rats fed
on the control SED (i.e., they exhibited none of the alterations
putatively induced by PED-feeding). This allowed us to rule out
that any other parameter altered on PED feeding could hide
the effects induced by portal glucose appearance. Glucose in-
fusion with both the above fluxes significantly decreased the
rats food intake compared to saline infusion (Figure 2). The de-
crease amounted to about 16% and 22% at 12 and 25 mol/
kg/min, respectively, at the beginning of the dark period, i.e.,
the time of preferential feeding in rodents (Figure 2A). The sup-
pression of intake was even more pronounced at the beginning
of the light period: −30% and –38% at 12 and 25 mol/kg/min,
respectively (Figure 2A). This was a specific effect of glucose
because there was no decrease in food intake caused by portal
infusions of other nutrient metabolites such as lactate (25
mol/kg/min) or alanine (25 mol/kg/min) (data not shown).
These data strongly suggested that portal glucose appear-
ance, as occurring on PED feeding during the postabsorptive
period, was able per se to account for the decreased food in-
take induced by the diet.
In a second approach, we studied rats fed on the PED (i.e.,
they exhibited all the alterations putatively induced by PED
feeding including endogenous IGR). In line with the results of
continuous food consumption monitored over several succes-
sive days (see above), food intakes tended to be lower than
those in the previous protocol involving the SED diet under the
three conditions of infusion (Figure 2A). However, the differ-
ences were not significant (p > 0.1) in this short-term fasting-
refeeding transition study. This might possibly be due to subtle324decreased food intake induced by glucose infusion. Rats were
Figure 2. Effect of glucose infusions on food intake in SED-fed (filled symbols)
and PED-fed (open symbols) rats
A) Effect of infusions of saline (0) or glucose (12 or 25 ml/kg/min) into the portal
vein in SED-fed (data from six rats, filled circles) and PED-fed rats (data from 6
rats, open circles) at the beginning of the dark phase; and in SED-fed rats at the
beginning of the light phase (data from eight rats, filled squares). The results are
the mean ± SEM: *, **, different from respective saline infusion p < 0.05 and p <
0.01, respectively (Student’s t test for paired values).
B) Effect of similar portal infusions in rats with capsaicin-treated portal vein (data
from five rats under each condition, symbols as above). Filled triangles refer to
an experiment of mechanical denervation of the portal vein (data from four rats).
C) Effect of infusions into peripheral blood (data from four rats, symbol as above).differences in the food behavior adaptation to this type of tran-
sition, which were out of the scope of the present study. It was
of note that portal glucose infusion at both rates was still able
to further decrease food intake compared to saline infusion
(Figure 2A). The decreases in regard to the control saline infu-
sion value were in the same order range as those in the proto-
col involving the SED diet. These data strongly suggested that
among the various parameters putatively altered by PED feed-
ing during the postabsorptive period, portal glucose appear-
ance has a dominant effect in relation to the control of food
intake.
Because the role of the portal glucose sensor in deriving
either the central response to hypoglycemia (Hevener et al.,
2000; Thorens and Larsen, 2004) or the activation of the central
areas involved in the response to portal glucose is established
(Adachi et al., 1984; Schmitt, 1973; Shimizu et al., 1983), we
further focused on the role of the portal nervous system in theCELL METABOLISM : NOVEMBER 2005
Intestinal gluconeogenesis diminishes food intaketreated by local application of capsaicin around the portal vein
at the time when portal catheters were inserted into the portal
vein (Jancso et al., 1980). Capsaicin is a neurotoxic agent in-
ducing the selective inactivation of weakly myelinated or unmy-
elinated autonomic afferent fibers (Blackshaw et al., 2000;
Holzer, 1991). After recovery, rats were studied for their food
intake in response to portal infusions as above. There was no
effect of portal glucose infusion on food intake in capsaicin-
treated rats, either during the dark or the light phase. This ab-
sence of effect was noted in SED-fed as in PED-fed rats (Figure
2B). It is known that, even if extreme care is taken during the
application, capsaicin might impact neighboring tissues and/or
nerve fibers (Zafra et al., 2004). Thus, portal vein denervation
was also mechanically performed (by gentle scrapping). The
results were identical to those in capsaicin-treated animals
(Figure 2B). However, one must bear in mind that nerve fibers
from the liver travel along the same way than those from the
portal vein. Therefore, it cannot be formally excluded that they
might also be impacted by the denervation treatment and that
a part of the glucose signal may be detected in the liver. Also,
because we did not check the neuroanatomical result of dener-
vation, it is possible that not all nerve fibers were impacted by
the treatment. However, it seems obvious that at least those
involved in the glucose signal transmission were inactivated.
At last, rats were fitted with indwelling catheters placed into
the right jugular vein instead of the portal vein. They were also
studied for food intake in response to saline or glucose infu-
sions. Again in line with the key role of portal vagal afferences
in the central control of food intake by portal glucose, there
was no alteration of food intake induced by glucose infusions
into this peripheral vein (Figure 2C).
We further ascertained that the hypophagia effect induced
by PED (see above) was dependent on the presence of a func-
tional portal glucose sensor. With this aim, rats were either de-
nervated around the portal vein as above (without catheter in-
sertion) or sham-operated (i.e., treated by local application of
saline instead of capsaicin around the portal vein). After recov-
ery for 7 days under SED feeding, they were further given either
the SED or the PED. After two days for familiarization with the
PED (see above), the growing rate of rats was studied during
5 more days. In line with former data, sham-operated rats fed
on the PED ate and grew less during the study period than
their counterparts fed on the SED. In contrast, in rats with inac-
tivated portal glucose sensor, there was no effect of PED on
food intake and the animals ate and grew as sham-operated
rats fed on the SED (Figure 3). This strongly suggested that the
PED-induced hypophagia was dependent on a functional por-
tal glucose sensor. It is interesting to note that the reversal of
PED effect by capsaicin disagreed with the hypothesis that a
lower palatability might account for the induced decrease in
food intake (see above). It was noteworthy that there was no
significant effect of portal denervation of the growing rate of
rats fed on the SED (Figure 3). The latter had the possibility to
sense portal glucose deriving from food assimilation and not
glucose deriving from gluconeogenesis (see Figure 1 and Table
2). This strongly suggested that the decreasing effect on food
intake promoted by portal glucose might not evidenced during
the periods of active food assimilation, possibly because of
redundant potent mechanisms of control of food intake con-
comitantly taking place (e.g., mechanical distension). Con-
versely, these results also emphasized that the control of foodCELL METABOLISM : NOVEMBER 2005Figure 3. Dependency of the sensitivity to PED feeding on the portal vein inner-
vation
The growing rate of sham-operated rats fed on the PED (filled squares) was
compared to rats with denervated portal vein fed on the same diet (open squares)
and to sham-operated rats (filled circles) and denervated rats (open circles) fed
on the SED. The results are the mean ± SEM from six rats per group. *, **,
different from value in counterparts with denervated portal vein, p < 0.05 and
p < 0.01, respectively (Student’s t test for unpaired values).intake depending on portal glucose sensing should be a mech-
anism essential in the periods of low portal appearance and
specific of glucose from intestinal gluconeogenic origin (a situ-
ation taking place in the postabsorptive period in rats fed on
the PED and/or when food assimilation is close to ending). In-
terestingly, our data are in keeping with previous results sug-
gesting that portal glucose infusion is important in determining
future food intake rather than in terminating ongoing meal
(Baird et al., 1997). It is likely that, when available, animals with
selective blockade of intestinal gluconeogenesis (e.g., mice
with targeted inactivation of Glc6Pase gene in the SI) will allow
not only to confirm our data, but also to address more in depth
these questions.
Activation of hypothalamic nuclei induced by portal
glucose appearance matches that induced
by protein feeding
Finally, we studied whether the hypophagia effects evidenced
in postabsorptive rats fed on PED, or in postabsorptive rats
fed on SED and infused with glucose into the portal vein, were
both consistent with the occurrence of central events taking
place in the main hypothalamic nuclei known to be involved in
the regulation of food intake. Because c-fos expression is a
well-recognized marker of neuronal activation (Halatchev and
Cone, 2005; Pocai et al., 2005), we studied c-fos expression in
the arcuate nucleus (ARC), the ventromedian nucleus (VMN),
the dorsomedian/paraventricular nucleus (DM/PVN), and lat-
eral hypothalamus (LH). The results shown in Figure 4 were
from the PVN, but it was noteworthy that infusions of glucose
into the portal vein or protein feeding elicited very similar c-fos
expressions in all aforementioned hypothalamic areas. The se-
lectivity of c-fos activation in these hypothalamic areas was
ascertained from photomicrographs showing larger brain areas325
A R T I C L EFigure 4. Induction of c-fos expression by portal glucose infusion or PED-feeding in rat hypothalamus
A–C) Photomicrographs showing c-fos-like immunoreactive neurons in PVN of normal rats infused into the portal vein with saline (A) or glucose at 25 mol/kg/min (B),
and of denervated rats infused with glucose (C). Magnification = 100×. 3V refers to third ventricle.
D) Number of c-fos-like immunoreactive neurons in arcuate nucleus (ARC), ventromedian hypothalamus (VM), dorsomedian hypothalamus (DM), paraventricular nucleus
(PVN), and lateral hypothalamus (LH). Saline and glucose infusions in normal rats: open and filled columns, respectively; Glucose infusion in denervated rats: gray
column. The results are expressed as the mean ± SEM of three rats per group; * different from saline, p < 0.05 (Student’s t test for unpaired values).
E–G) Photomicrographs showing c-fos-like immunoreactive neurons in PVN of normal rats fed on SED (E) or PED (F) and of denervated rats fed on PED (G).
H) Number of c-fos-like immunoreactive neurons in ARC, VM, DM, PVN, and LH. SED-fed and PED-fed normal rats: open and filled columns, respectively; PED-fed
denervated rats: gray columns. Magnification and expression of results as above.326 CELL METABOLISM : NOVEMBER 2005
Intestinal gluconeogenesis diminishes food intake(Figure S1 in the Supplemental Data available with this article
online). The number of c-fos immunoreactive neurons was in-
creased by a factor of 2 to 3 in all areas in postabsorptive
rats infused with glucose compared to control rats infused with
saline (Figures 4A, 4B, and 4D). The increases were quantita-
tively comparable in postabsorptive rats fed on PED in regard
to control rats fed on SED (Figures 4E, 4F, and 4H). In contrast,
there was no increase in c-fos labeling in any of these areas in
rats in which the portal vein had been denervated (Figure 4C,
4D, 4G, and 4H). It may appear paradoxical that activation took
place in the LH, especially because the latter has been classi-
cally considered as a feeding center (global destruction of the
LH leading to hypophagia) and because reciprocal relation-
ships between activities of the LH and VMH (conversely as-
sumed to be a satiety center) were previously reported (Anand,
1961; Oomura et al., 1964). However, changes in the neuronal
activity in the LH promoted by portal glucose were already re-
ported (Schmitt, 1973; Shimizu et al., 1983). Moreover, one
cannot predict from c-fos activation the final effect of those
neurons that were selectively activated by PED or portal glu-
cose in the LH. Further identifications of the neuromediators
expressed in the c-fos-activated neurons by double labeling
experiments would allow to specify the mechanisms induced
by glucose and/or diet proteins. However that may be, our data
strongly suggested that the central hypothalamic events elic-
ited either by portal glucose infusion or PED-feeding were sim-
ilar, and as a whole resulted in decreasing food intake.
In conclusion, we report in this study that protein feeding
markedly increases the expression of the regulatory genes of
gluconeogenesis in the SI in rats. This promotes endogenous
glucose synthesis and release into the portal blood, a phenom-
enon lasting during the postabsorptive time, i.e., after the
period of assimilation of food glucose. This portal glucose flux,
sensed by the portal glucose sensor, is able per se to activate
the hypothalamic nuclei involved in the regulation of food in-
take and to cause a decrease in subsequent food consump-
tion. As such, these results provide an answer to the question
of how protein-enriched meals decrease hunger and induce
hypophagia, unsolved up to now (Barkeling et al., 1990; Booth
et al., 1970; Jean et al., 2001; Rolls et al., 1988; Westerterp-
Plantenga, 2003). Together with other recent results (Abbott et
al., 2005; Gutierrez-Juarez et al., 2004; Peters et al., 2005; Po-
cai et al., 2005), our data further point out the connection be-
tween the central nervous system and the integrated digestive
system, and the crucial role of the vagal transmission in the
central control of energy homeostasis. Moreover, they bring to
light a novel concept of control of food intake, involving the
SI glucose metabolism as a key relay from the macronutrient
composition of the diet to the amount of food ingested. Be-
cause gluconeogenesis is present in the human intestine (Bat-
tezzati et al., 2004; Mithieux et al., 2004b; Rajas et al., 1999,
2000), and protein-induced diminution of hunger concerns hu-
man beings (Barkeling et al., 1990; Booth et al., 1970; Rolls et
al., 1988), the SI glucose metabolism may be a new target in
the treatment of food intake disorders.
Experimental procedures
Animals and tissues sampling
Rats weighing 260–280 g were acclimated to our animal house under con-
trolled temperature (22°C) and light conditions (light/dark, 12 hr/12 hr) with
free access to water and SED diet. The composition of the diets was essen-CELL METABOLISM : NOVEMBER 2005tially based on that of a standard chow diet, as previously described
(Mithieux et al., 2002), with modifications in the ratio starch-glucose/protein,
that was 50%/17% in SED and 17%/50% in the PED (weight basis), respec-
tively. Protein was a mixture of soya protein and casein (50/50). All experi-
ments intended for tissue sampling were performed in the postabsorptive
state, i.e., 6 hr after food removal, a time when food absorption was com-
pleted. The intestine was sampled essentially as described (Mithieux et al.,
2004a). All procedures for gene expression analyses were previously de-
scribed in detail (Mithieux et al., 2004a; Rajas et al., 1999, 2000).
Glucose flux measurements
Rats in the postabsorptive state were anaesthetized with pentobarbital (70
mg/kg), fitted with catheters and infused with [3-3H] glucose as previously
described (Croset et al., 2001; Mithieux et al., 2004a). After infusion for 10
min, a laparotomy was performed, the inferior mesenteric circulation was
stopped by ligatures to exclude the blood flow coming from the cecum and
the colon. After 90 min, a time where a steady state of glucose SA was
obtained (Croset et al., 2001), blood was gently sampled simultaneously in
the carotid artery and in the portal vein, using a catheter inserted into a
superior mesenteric vein and pushed up to the junction with pancreaticodu-
odenal vein. Total EGP was obtained from the [3-3H] glucose infusion rate
and the SA of arterial glucose (Croset et al., 2001; Mithieux et al., 2002).
The FX represents the fraction of [3-3H] glucose removed by the SI. It was
calculated as [([3-3H] glucose SAartery × glucose concentrationartery) – ([3-
3H] glucose SAvein × glucose concentrationvein)]/[([3-3H] glucose SAartery ×
glucose concentrationartery). The intestinal glucose uptake (IGU) was de-
duced from this FX, the arterial plasma glucose and the intestinal blood
flow (IBF): IGU = IBF × plasma glucose concentrationartery × FX. The deter-
mination of IBF using radiolabeled microsphere technique was previously
described (Croset et al., 2001). The intestinal glucose balance (IGB) is the
net result of both the uptake and release of glucose by the SI. It was calcu-
lated from the difference between the arterial and venous glucose concen-
trations and IBF, as IGB = IBF × (glucose concentrationartery − glucose con-
centrationvein). Finally, the intestinal glucose release (IGR) was derived from
IGB and IGU by resolving: IGB = IGU − IGR.
All procedures used for determinations of plasma glucose, insulin, and
glucose SA were described in detail previously (Croset et al., 2001; Mithieux
et al., 2004a). Plasma CCK concentration was determined by radioimmuno-
assay after ethanol extraction, as previously described (Miazza et al., 1985).
The crossreactivity of the antibody used with gastrin was less than 1%.
Studies in conscious animals
To equip them with indwelling catheters, rats were anesthetized by intra-
peritoneal injection of pentobarbital (70 mg/kg). In rats intended for infu-
sions into portal blood, a laparotomy was performed. A polyethylene cathe-
ter was inserted into a superior mesenteric vein, pushed up to the junction
with pancreaticoduodenal vein, and secured with biological glue. A passage
under the skin up to the basis of the neck was done to recover the other
end of the catheter, which was secured with a dacron mesh button tether
(Harvard apparatus). In rats intended for inactivation of portal vein innerva-
tion, a gauze compress moistened with 80 l of a solution of capsaicin (10
mg/ml) in water:ethanol:tween 20 (8:1:1, vol/vol), was applied around the
portal vein for 15 min at the time of surgery. In rats intended for infusions
in peripheral blood, the indwelling catheter was inserted into the right jugu-
lar vein, and the other end recovered at the basis of the neck as above.
After sewing up the incisions, rats were allowed to recover from surgery for
one week with free access to SED and water. A solution of polyvinylpyrroli-
don (7% (w/w) in saline, 200 l) was infused each day to prevent coagu-
lation.
In food intake experiments, 4 hr before the food consumption period, rats
were placed into individual cages without food, with free access to water,
and were infused with either saline or glucose (12 or 25 mol/kg/min). At
the time when the conditions of illumination changed (beginning of dark or
light), they were given SED (or PED) for 3 hr while infusion was maintained.
The latter time was supposed to match the transition from postprandial to
postabsorptive period. The amount of food ingested was monitored at the
end of this 3 hr time. Each rat was studied at least two to three times with
either solution, infused in a random order. Mean values were first calculated
for each solution in each rat taken individually. These values were then used327
A R T I C L Eto calculate a mean value for each solution in each group, and to carry out
statistical analysis.
To c-fos immunochemistry experiments, rats were infused under the
same conditions as above, except that they were not given food when illu-
mination changed. Infusions were prolonged for 2 additional hr before anes-
thesia and further brain postfixation (see below).
All protocols used in this work were performed according to the recom-
mendations of our local animal ethics committee for animal experimen-
tation.
c-fos immunochemistry
To allow valuable comparison with rats with portal infusions (see above),
animals fed either on SED or PED were anesthetized 6 hr after removal of
food. When portal vein denervation was involved, it was performed 7 days
before the experiments as in the study relative to Figure 3. After anesthesia,
rats were transcardiacaly infused with ice-cold 0.9% saline for 10 min, fol-
lowed by 4% paraformaldehyde in PBS (phosphate-buffer saline) infusion
for 20 min. The brains were removed, postfixed in ice cold 4% paraformal-
dehyde for 2 hr and cryoprotected in 30% sucrose in PBS for 2–3 days, at
4°C. They were then frozen and cut into 40 m coronal sections using a
freezing cryostat. The sections were exposed to 0.3% hydrogen peroxide
for 30 min. They were then preincubated in PBS containing 3% normal goat
serum and 0.25% Triton (blocking solution) for 2 hr, and further incubated
for 48 hr with rabbit polyclonal c-fos antiserum (1/20,000 dilution; Ab-5,
Oncogene Sciences, San Diego, California) in blocking solution. Subse-
quently, the sections were incubated with biotinylated goat anti-rabbit IgG
diluted at 1/600 (Vector Laboratories, Burlingame, California) for 1 hr, and
with streptavidin horseradish peroxidase for 30 min, both in blocking solu-
tion. C-fos expression was visualized for fos-like immunoreactivity (FLI)
using diaminobenzidine and hydrogen peroxide. A BH2 microscope (Olym-
pus Corp, Melville, New York) connected via a color video camera to a PC
computer using the Imagenia 2000 software (Biocom, Les Ullis, France) was
used for cell counting. Each stained section was screened for visualization
of FLI in neurons. In the regions of interest, fos-positive nuclei were counted
following the area outlined, on numerous sections and on both sides, ac-
cording to The Rat Brain in Stereotactic Coordinates (Paxinos and Wat-
son, 1998).
Supplemental data
Supplemental Data include one figure and can be found with this article
online at http://www.cellmetabolism.org/cgi/content/full/2/5/321/DC1/.
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